Nano-X Imaging faces March 29, 2027 Nasdaq deadline
Nano-X Imaging (NNOX) received a Nasdaq notice that its shares no longer meet the minimum bid-price requirement of $1.00. The company has until March 29, 2027, to regain compliance, with a potential 180-day extension if it transfers to Nasdaq Capital Market. NNOX is considering options to meet the requirement.
How this was made
The 30-second read
Why it matters
The notice signals heightened risk for shareholders and may trigger short‑selling activity.
Market read
Regulatory compliance risk for a micro‑cap listed on Nasdaq; potential price volatility ahead of the deadline.
What to watch
Potential for a 180‑day extension if the company moves to the Capital Market, and any undisclosed share‑buyback plans that could lift the price.
Background
Nasdaq requires listed companies to maintain a minimum $1.00 closing bid price for at least 10 consecutive trading days. Failure triggers a delisting notice and a compliance deadline.
Ticker impact
Nasdaq notified Nano-X Imaging that its shares fell below the $1.00 bid-price requirement and set a compliance deadline of March 29, 2027.
downward pressure as investors price in potential delisting risk
Bid-price non‑compliance is a material regulatory issue for a micro‑cap; no remedial action has been announced.
Market effects
May affect other low‑price Nasdaq‑listed biotech and imaging firms facing similar compliance thresholds.
Limited to U.S. listed micro‑caps; no broader regional effect.
Minimal global impact; primarily a company‑specific regulatory issue.
Counterpoint
If Nano‑X can secure a capital raise or transfer to Nasdaq Capital Market, the compliance deadline could be a catalyst for a short‑term rally.
Key entities
- companyNano‑X Imaging Ltd.
US‑listed imaging technology firm facing bid‑price compliance issue.
- exchangeNasdaq
Regulatory body issuing the compliance notice.
